questionText: To ask the Secretary of State for Health and Social Care, with reference to the guidance by NICE entitled Covid-19 rapid guideline: managing symptoms including at the end of life in the community, NG163, published on 3 April 2020, by what process (a) that guidance was commissioned and (b) the NHS decided (i) to procure Midazolam for use in (A) end-of-life and (B) other patient care and (ii) the quantity of Midazolam it would procure in each of the last four years.
answerText: The National Institute for Health and Care Excellence (NICE) guideline NG163 published in 2020 was commissioned as part of a programme to provide rapid guidance on the management of affected patients with COVID-19. Several of NICE’s COVID-19 rapid guideli...
heading: Midazolam